ATW 2024: Looking Ahead in Cell & Gene Therapy

Published on February 12, 2024
ATW 2024: Looking Ahead in Cell & Gene Therapy

Our team returned from Advanced Therapies Week 2024 in Miami energized and excited about the future of gene and cell therapy. We had many great conversations with customers and prospects, and noticed a few key themes that could shape much of the work being done this year. 

Continue reading on website
Other news

InnovAge to Host Investor Day on February 27, 2024

February 8, 2024
DENVER, Feb. 08, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today

European Pharmaceutical Manufacturer: Overcoming ADC Challenges with ThioBridge

February 13, 2024
Abzena’s CSO, Dr Campbell Bunce was recently featured in an article in European Pharmaceutical Manufacturer’s latest issue, entitled:  Q&A: Overcoming ADC Challenges with Abzena’s ThioBridge PlatformAccess the full article hereEPM Editor Jai McIntosh recently caught up with Campbell Bunce, Chief Scientific Officer and Cambridge Site Head at Abzena to discuss Abzena’s ThioBridge technology.Jai: Cou